Regranex

This page contains recent news articles, when available, and an overview of Regranex but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Cardium Therapeutics reports positive findings from Excellarate Phase 1/2 ...  -  ‎Oct 19, 2009‎
Becaplermin (Regranex®, platelet-derived growth factor-B homodimer [PDGF-BB], Systagenix Wound Management, Gargrave, UK) is the only growth factor protein ... News-Medical.net

FDA: diabetic foot gel Regranex may increase cancer …  -  Mar 28, 2008
BEIJING, March (Xinhuanet) -- The Food and Drug Administration of US(FDA) said that a Johnson & Johnson foot gel called Regranex used by diabetics may ... 新�?�网

Cancer risk seen with J&J foot gel: FDA  -  Mar 27, 2008
Regranex, approved for US patients in 1997, is a prescription gel used to treat diabetic leg and foot wounds. "At this time, FDA believes that there may be ... Reuters UK

FDA orders boxed warning for Regranex  -  Jun 9, 2008
WASHINGTON, June 9 (UPI) -- The US Food and Drug Administration announced the addition of a boxed warning for Regranex (becaplermin) because of an increased ... United Press International

REGRANEX(R) (Becaplermin) Gel Is Effective Treatment Of Diabetic …  -  Jan 30, 2006
Johnson & Johnson Wound Management, a division of ETHICON, INC., today announced the publication of results in a study designed to estimate the ... Medical News Today - Medical News Today (press release)

J&J adds cancer warning to diabetic foot gel  -  Jun 7, 2008
The study compared data among 1622 patients exposed to Regranex and 2809 similar ... Johnson & Johnson's Ethicon unit, which sells Regranex, said the new ... Reuters India

Regranex Top : User Ratings covering uses, effectiveness, interactions...  -  Dec 4, 2007
My bf had a very stubborn diabetic ulcer on the bottom of his foot, of course, on a pressure point. The regranex was fabulous. We had struggled to heal this ... WebMD

Fidelity's top lawyer resigns to be full-time law teacher  -  Jun 7, 2008
The FDA added its most serious warning to the company's cream Regranex, which is prescribed to treat severe foot and leg ulcers in diabetics. ... Boston Globe

Press Release: Recent Study Confirms REGRANEX Gel to be Effective …  -  Jan 23, 2006
Recent Study Confirms REGRANEX Gel to be Effective Treatment of Diabetic Neuropathic Foot Ulcers. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

… , INC. Announces Revised Label For REGRANEX(R) (becaplermin) Gel …  -  Jun 6, 2008
ETHICON, INC. Announces Revised Label For REGRANEX(R) (becaplermin) Gel 0.01%. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research

Regranex Foot Gel Gets Stiffer Warnings  -  Jun 11, 2008
Ortho-McNeil, a subsidiary of Johnson & Johnson, this week sent letters to physicians notifying them of a boxed warning for Regranex, a cream used to treat ... PharmExec.com

… : FDA Announces New Labeling Changes for Regranex Product to carry ...  -  Jun 9, 2008
FDA Announces New Labeling Changes for Regranex Product to carry boxed warning. from M2 Presswire. Highbeam Research – FREE Trial. Pay-Per-View - M2 Presswire - HighBeam Research

Boxed Warning Added to J&J's Regranex Gel  -  Jun 16, 2008
A boxed warning of an increased risk of death from cancer has been added to labeling for Johnson & Johnson's (J&J) Regranex Gel. ... FDA news - FDA news (subscription)

FDA slaps black box onto J&J's Regranex; Biovail proxy battle...  -  Jun 9, 2008
...> The FDA put a new black-box warning on Johnson & Johnson's foot ulcer medication Regranex, saying that using large amounts of the cream could heighten ... FiercePharma

Article: Boxed warning added to diabetic foot and leg ulcer drug.(News...  -  Sep 1, 2008
It is marketed as Regranex Gel 0.01% for treating nonhealing diabetic leg ... Report serious or unexpected adverse events associated with Regranex to the ... Pay-Per-View - Internal Medicine News - HighBeam Research

｜科技�?�命｜科技新�?�｜中時電�?報  -  Nov 16, 2007
...根據生產Regranex的藥�?公�?�調查，全�?�在處�?�慢性傷�?�癒�?�的花費�?年高�?�五�??億到七 �??億美元，市場穩定�?長，以糖尿病病足潰�?為例，其平�?�年�?長率為八．三％。 ... 中時電�?報

US regulators include cancer risk on labels of J&J's Regranex  -  Dec 23, 2008
The FDA on Friday added new information to the labels of Johnson & Johnson's Regranex, warning patients of increased cancer risks tied to using large ... SmartBrief

Private Equity Offer for J&J Wound Care Unit  -  Jul 1, 2008
Ethicon's wound care products include Promogran wound dressing and Regranex, a prescription gel for treating foot ulcers caused by diabetes. ... NJBIZ

Boxed warning added to foot/leg ulcer gel.(News) | Article from Skin...  -  Jul 1, 2008
It is marketed as Regranex gel 0.01% for the treatment of nonhealing ... The incidence of cancer was not in creased among those in the Regranex group, ... Pay-Per-View - Skin & Allergy News - HighBeam Research

Boxed warning added to diabetic ulcer treatment.(News) | Article from...  -  Jul 1, 2008
It is marketed as Regranex Gel 0.01% for treating nonhealing diabetic leg ... The incidence of cancer was not increased among those in the Regranex group, ... Pay-Per-View - Family Practice News - HighBeam Research

Adjunctive treatments for wound healing in the diabetic foot.  -  Sep 22, 2006
These included a pivotal study of 382 people, which showed that Regranex Gel ... 3 Platelet-derived growth factor BB (Regranex) stimulates fibroblasts and ... $4.95 - Diabetic Foot - ECNext

美國疑致癌藥�?Regranex 本港沒有註冊  -  Mar 30, 2008
...美國食�?和藥物管�?�局表示，強生公�?�生產的糖尿病患者使用藥�?Regranex ， �?�能有致癌風險。本港衞生署表示， Regranex 藥�?並沒有在港註冊，當局會跟進。 ... 香港電�?� - 香港電�?�

强生公�?�一�?��?或有致癌风险  -  Mar 31, 2008
Regranex是美国FDA于1997年批准的一�?治疗糖尿病患者腿�?脚溃疡的�?��?。 ... 美�?�管局说，调查�?�现�?常使用这�?�??为Regranex的�?��?的患者中，因癌症死亡的人数有所增加 ... 央视国际

BioMimetic Therapeutics Receives Written Communication from FDA …  -  Apr 21, 2008
Both GEM OS1 and Regranex contain recombinant human platelet-derived growth factor (rhPDGF-BB) (becaplermin) as the active ingredient. ... Genetic Engineering News - Genetic Engineering News (press release)

FDA：强生公�?�一�?供糖尿病患者使用�?��?�?�能有致癌风险  -  Mar 30, 2008
...美�?�管局说，调查�?�现�?常使用这�?�??为Ｒｅｇｒ�?ｎｅｘ的�?��?的患者中，因癌症 ... Ｒｅｇｒ�?ｎｅｘ是美国ＦＤＡ于１９９７年批准的一�?治疗糖尿病患者腿�?脚溃疡的 ... 新�?�网

EEUU endurece la etiqueta de un gel para las úlceras de pacientes …  -  Jun 6, 2008
El producto, que se comercializa también en España como Regranex ... Regranex es una crema que se emplea para ayudar a cicatrizar las lesiones y úlceras en ... elmundo.es

eluniverso.com | 09h34 Revelan riesgo de cáncer por uso de gel para …  -  Mar 28, 2008
Regranex, aprobado en Estados Unidos en 1997, es un gel de venta bajo prescripción empleado para tratar las heridas en piernas y pies en los diabéticos. ... El Universo

強生一種供糖尿病患者使用藥�?存致癌風險  -  Mar 30, 2008
...美藥管局說，調查發�?�經常使用這種�??為Regranex的藥�?的患者中，因癌症死亡的人數有所增加 ... Regranex是美國FDA於1997年批准的一種治療糖尿病患者腿�?腳潰�?的藥�?。 ... 人民网

Gel para úlceras aumenta mortes por cancro  -  Jun 9, 2008
Assim, a agência emitiu um comunicado em que diz que "o Regranex não é ... Nos Estados Unidos, a empresa que detém o Regranex já adicionou um aviso sobre ... Diário de Notícias - Lisboa

Atlanta health, diet and fitness news | ajc.com  -  Jun 6, 2008
A study found that patients who used three or more tubes of Regranex had a fivefold ... "Regranex is not recommended for patients with known malignancies. ... Atlanta Journal Constitution

مرهم لتقرحات القدمين يسبب السرطان  -  Jun 8, 2008
وجاء �?ي أكثر التحذيرات جدية، الذي أطلقته الدائرة ال�?درالية حول مرهم Regranex الشائع ... القبس

Diabete: maggiore incidenza di tumore con l'uso di Regranex  -  May 20, 2008
Martedì 20 Maggio 2008 - L'FDA è venuta a conoscenza delle conclusioni di uno studio che è stato eseguito per esaminare la possibilità di un aumentato ... XagenaSalute

Ри�?к онкопатологии при применении Regranex  -  Apr 21, 2008
27 марта FDA �?ообщило о получении информации об и�?�?ледовании, проведенном дл�? изучени�? возможно�?ти повышени�? ри�?ка онкологиче�?ких заболеваний у пациентов �? ... �?птека online

Erhöhte Krebssterblichkeit durch Wundgel Regranex®?  -  Mar 28, 2008
Washington – Die Behandlung von diabetischen Geschwüren mit dem Wundgel Regranex® erhöht möglicherweise das Krebsrisiko. Dies zeigt eine neue Studie, ... Deutsches Ärzteblatt

Wundgel Regranex kann Krebswachstum fördern  -  Jun 10, 2008
Washington – Die US-amerikanische Zulassungsbehörde FDA hat einen umrahmten Warnhinweis (boxed warning) für die Fachinformation des Wundgels Regranex® ... Deutsches Ärzteblatt

治疗糖尿病�?�物�?�能致癌  -  Jun 23, 2008
...黄红维美国食�?�?��?监�?�管�?�局(FDA)近日警告说：使用Regranex(是一�?糖尿病性溃疡 ... 美国食�?�?��?监�?�管�?�局已�?求Regranex的制造商在该�?�的包装盒上注明“黑箱�?标志 ... 新�?�网河�?�频�?�

Press Release: Manufacturers of Some Diabetes Drugs to Strengthen …  -  Aug 15, 2007
Article: FDA Announces New Labeling Changes for Regranex Product to carry ... M2 Presswire; June 9, 2008 ; 700+ words ... ... Changes for Regranex Product ... Pay-Per-View - M2 Presswire - HighBeam Research

BioMimetic Therapeutics (BMTI): Deutsche Bank reits Buy and $22 tgt -...  -  Apr 3, 2008
Based on all his work with Regranex, Dr. Weiman does not believe there is a causal relationship between Regranex (or PDGF) and carcinogenesis/cancer deaths. ... StreetInsider.com - StreetInsider.com (subscription)

Small Cap Review Small Cap Stocks to Watch - BMTI, CYCL  -  Mar 28, 2008
The FDA communication specifically addresses Regranex use and does not address other rhPDGF-BB containing products. BioMimetic has not received any ... TransWorldNews - TransWorldNews (press release)

Sotaliraq.com - صوت العراق  -  Jun 7, 2008
وجاء �?ي أكثر التحذيرات جدية، الذي أطلقته الدائرة ال�?يدرالية حول مرهم Regranex الشائع ... صوت العراق

OrthoLogic Corp. at Gabelli & Company, Inc. The 2nd Annual …  -  Feb 22, 2005
Using a target average selling price, which Regranex has, we see this is at least, again, a $2 billion market opportunity. Both of these 2 products, ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com

Press Release: FDA Requests Boxed Warning for Contrast Agents Used …  -  May 23, 2007
Article: FDA Announces New Labeling Changes for Regranex Product to carry ... M2 Presswire; June 9, 2008 ; 700+ words ... ... Changes for Regranex Product ... Pay-Per-View - M2 Presswire - HighBeam Research

Press Release: FDA approves updated labeling with boxed warning and …  -  Jan 20, 2006
Article: FDA Announces New Labeling Changes for Regranex Product to carry ... M2 Presswire; June 9, 2008 ; 700+ words ... ... Changes for Regranex Product ... Pay-Per-View - M2 Presswire - HighBeam Research

BioMimetic up despite FDA note  -  Mar 28, 2008
Regranex is used chronically, between one and three times per day, ... "Bottom line, we think investors have overreacted to the Regranex news and would be ... Boston Globe

治疗糖尿病�?�物�?�能致癌  -  Jul 24, 2008
...美国食�?�?��?监�?�管�?�局已�?求Regranex的制造商在该�?�的包装盒上注明“黑箱�?标志的警告。 ... 在�?求制造商注明警告的�?�时，FDA还�?求医生在用Regranex治疗时�?�?�衡 ... 中�?�网

Press Release: Small Cap Stocks to Watch - BMTI, CYCL, BEST, CPYE. - ...  -  Mar 28, 2008
The FDA communication specifically addresses Regranex use and does not address other rhPDGF-BB containing products. BioMimetic has not received any ... Pay-Per-View - M2 Presswire - HighBeam Research

Missouri Case Law - STATE v. BARNES, 245 SW3d 885 (Mo.App.ED …  -  Feb 19, 2008
She saw that the statement contained a billing for the drug Regranex on 9 June 2003, ... She had never used Regranex nor had a prescription for it. ... Pay-Per-View - Missouri Case Law - Loislaw

Briefing  -  Mar 28, 2008
The Food and Drug Administration said a study of the gel, Regranex, ... Regranex, approved for U.S. patients in 1997, is used to treat diabetic leg and foot ... Pay-Per-View - Newsday - ProQuest Archiver

Unusual 11 Mid-Day Movers 4/3: USU, MF, PCX, BMTI Higher; TGIC, …  -  Apr 3, 2008
Based on all his work with Regranex, Dr. Weiman does not believe there is a causal relationship between Regranex (or PDGF) and carcinogenesis/cancer deaths. ... StreetInsider.com - StreetInsider.com (subscription)

Investor Group acquires Ortho Organizers Inc through a leveraged...  -  Aug 5, 2005
It is thought that Astex…s board in August but investors soon criticized the offer for…in Regranex Gel, developed with Ortho - McNeil through a ... Pay-Per-View - deals - Alacra Store

Becaplermin improves healing of diabetic neuropathic foot ulcers.( …  -  Aug 1, 2005
In a retrospective cohort study of 25098 patients, 10% were treated with becaplermin (Regranex), a topical recombinant human platelet-derived growth factor ... Pay-Per-View - Family Practice News - Factiva, from Dow Jones

Autoridades advertem que remédio para diabetes pode gerar câncer  -  Mar 27, 2008
O Regranex (becaplermin) é um remédio de uso tópico que se aplica diretamente em úlceras nos pés e nas pernas de doentes de diabetes. ... G1.com.br

Press Release: CHAT LIVE in the only dedicated CHAT ROOM for ( …  -  Mar 28, 2008
The FDA communication specifically addresses Regranex use and does not address other rhPDGF-BB containing products. BioMimetic has not received any ... Pay-Per-View - M2 Presswire - HighBeam Research

Article: William L. Brower, Jr.: Management accounting advocate.(Chang...  -  Aug 1, 2006
..."Ortho-McNeil Pharmaceutical is receiving the FPME's highest ... Fischer, President, Ortho-McNeil Pharmaceutical, Inc. REGRANEX is the first biologic ... ... Pay-Per-View - Strategic Finance - HighBeam Research

Merger and Acquisition Scenario  -  Apr 15, 2006
Regranex (Beclapermin); Betaseron (Interferon Beta-1b); TOBI (Tobramycin); (Tobi) Inhalable ... Regranex (Beclapermin). Immunology. Autoimmune Disorders ... $250.00 - Revere Reports - Revere

BioMimetic Therapeutics Reports 2008 First Quarter Results  -  May 8, 2008
This letter followed a posting on the FDA website of an Early Communication concerning the Agency's ongoing safety review of Regranex(R), ... Genetic Engineering News - Genetic Engineering News (press release)

Merger and Acquisition Scenario  -  Apr 15, 2006
Buyer (Total: 42). Regranex (Beclapermin); Betaseron (Interferon Beta-1b); TOBI (Tobramycin); (Tobi) Inhalable Tobramycin ... $250.00 - Revere Reports - Revere

As New Products Arrive, Wound Care Sales Grow  -  Aug 5, 2005
Johnson & Johnson, meanwhile, makes Regranex, a wound care gel incorporating blood-cell derived proteins that promote the early stages of healing. ... New York Times

Merger and Acquisition Scenario  -  Apr 15, 2006
Regranex (Beclapermin); Betaseron (Interferon Beta-1b); TOBI (Tobramycin) ... Regranex (Beclapermin). Hematology. White Blood Cell (WBC) Disorders ... $250.00 - Revere Reports - Revere

FDA issues early-warning trifecta  -  Mar 28, 2008
New data on Johnson & Johnson's foot and leg ulcer drug Regranex seems to show that patients have a higher death rate from cancer. ... FiercePharma

生技�?破�?��?�將�?�FDA申請新藥人體臨床實驗  -  Aug 29, 2007
...�?�瑞鈺表示，�?�行美國唯一核�?�治療糖尿病傷�?�癒�?�的上市藥物�?��?�Regranex ，DCB-WH1 �?但具有與Regranex相似效用的傷�?�癒�?�能力，更�?�?的是DCB-WH1是由�?物來�?組�?， ... epochtimes.com

Press of Atlantic City, The (NJ)  -  Jun 7, 2008
The FDA added its most serious warning to the company's cream medication Regranex, which is prescribed to treat severe foot and leg ulcers in diabetics. ... $2.95 - Press of Atlantic City, The - NewsBank

Biopharmaceuticals: approval trends in 2005: in 2005, 10 …  -  Aug 1, 2006
The active biotech ingredient of GEM 21S, on the other hand, is identical to the active ingredient in Regranex, a product approved in 1997. ... $4.95 - Biopharm International - ECNext

Research And Markets: Study This Medical Review Criteria Guidelines …  -  Feb 10, 2005
Erythropoeitin Therapy; Experimental Drug Therapy; Chelation therapy; Diabetes management therapy/supplies; Diabetic foot ulcers - Regranex gel therapy; ... Free with registration - Business Wire - AccessMyLibrary.com

Merger and Acquisition Scenario  -  Apr 15, 2006
Buyer (Total: 42). Regranex (Beclapermin); Betaseron (Interferon Beta-1b); TOBI (Tobramycin); (Tobi) Inhalable Tobramycin ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Apr 15, 2006
Regranex (Beclapermin); Betaseron (Interferon Beta-1b); TOBI (Tobramycin); (Tobi) Inhalable ... Regranex (Beclapermin). Immunology. Autoimmune Disorders ... $250.00 - Revere Reports - Revere

Article: Delayed oral wound healing linked to depression.(Clinical …  -  Nov 1, 2005
Article: Gel Speeds Healing of Acute Wounds.(Regranex (becaplermin) ... ... Regranex), a commercially available, platelet-derived growth factor (PDGF), ... Pay-Per-View - Skin & Allergy News - HighBeam Research

Merger and Acquisition Scenario  -  Apr 15, 2006
Buyer (Total: 42). Regranex (Beclapermin); Betaseron (Interferon Beta-1b); TOBI (Tobramycin); (Tobi) Inhalable Tobramycin ... $250.00 - Revere Reports - Revere

Novartis Vacaville facility to expand  -  Aug 31, 2007
This month, it's producing a protein for a division of Johnson and Johnson which goes into the manufacture of Regranex, a topical gel used to treat diabetic ... Bizjournals.com

Drug/Medical Device  -  Apr 15, 2006
Regranex (Beclapermin), Lower Extremity Diabetic Neuropathic Ulcers, Infection, Cellulitis, Osteomyelitis, Erythematous Rashes, Approved. Immunology ... $70.00 - Revere Reports - Revere

Гель дл�? ног, пропи�?анный диабетикам, может приве�?ти к �?мерти  -  Mar 28, 2008
Regranex — гель, который назначает�?�? пациентам, больным диабетом, дл�? заживлени�? ран на ногах. Barbara Montresor, одна из разработчиков гел�?, �?читает, ... Медицин�?ка�? информационна�? �?еть

Research And Markets: Study This Medical Review Criteria Guidelines …  -  Feb 10, 2005
Erythropoeitin Therapy; Experimental Drug Therapy; Chelation therapy; Diabetes management therapy/supplies; Diabetic foot ulcers - Regranex gel therapy; ... $4.95 - Business Wire - ECNext

Brain Able to Detect Calorie Content of Food: Study  -  Mar 28, 2008
Safety reviews of Regranex Gel (becaplermin), Ziagen (abacavir) and Videx ... The review of Regranex Gel, a skin product used to heal leg and foot ulcers, ... DentalPlans.com

BiotechEast - Taiwan and China biotechnology, medical devices, …  -  Feb 10, 2008
In the US, Regranex is the only FDA approved diabetic foot ulcer wound healing ... In comparison to Regranex, WH-1 has similar wound healing efficacy, ... Biotecheast.com

Merger and Acquisition Scenario  -  Apr 15, 2006
Regranex (Beclapermin); Betaseron (Interferon Beta-1b); TOBI (Tobramycin) ... Regranex (Beclapermin). Hematology. Phase I/Phase II Clinical Stage Products ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Mar 11, 2006
Regranex (Beclapermin); Betaseron (Interferon Beta-1b); Proleukin (Aldesleukin); CHIR-12.12 (Anti-CD40). Target. n/a. Business Relationship Summary: ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Apr 15, 2006
Buyer (Total: 42). Regranex (Beclapermin); Betaseron (Interferon Beta-1b); TOBI (Tobramycin); (Tobi) Inhalable Tobramycin ... $250.00 - Revere Reports - Revere

Press Release: Budco Grows In Key Areas. - PR Newswire | HighBeam …  -  Feb 6, 2006
..."Ortho-McNeil Pharmaceutical is receiving the FPME's highest ... Fischer, President, Ortho-McNeil Pharmaceutical, Inc. REGRANEX is the first biologic ... ... Pay-Per-View - PR Newswire - HighBeam Research

Foot procedure gets diabetics back on their feet.(Clinical Rounds)( …  -  Aug 1, 2006
Specialized matrix dressings like Promogran and wound-healing gels like Regranex, which contain growth factors to stimulate ... Regranex. ... Pay-Per-View - Family Practice News - HighBeam Research

Competitors by Product Report  -  Apr 15, 2006
Products:. Regranex (Beclapermin). Johnson & Johnson (JNJ) Products:. Regranex (Beclapermin). Immunology. Autoimmune Disorders. Multiple Sclerosis (MS) ... $75.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Apr 15, 2006
Buyer (Total: 42). Regranex (Beclapermin); Betaseron (Interferon Beta-1b); TOBI (Tobramycin); (Tobi) Inhalable Tobramycin ... $250.00 - Revere Reports - Revere

Merger and Acquisition Scenario  -  Apr 15, 2006
Regranex (Beclapermin); Betaseron (Interferon Beta-1b); TOBI (Tobramycin); (Tobi) Inhalable ... Regranex (Beclapermin). Immunology. Autoimmune Disorders ... $250.00 - Revere Reports - Revere

Becaplermin tied to cancer death risk.(Skin Disorders) | Article from...  -  Apr 15, 2008
Instead, "the risk of using Regranex should be weighed against the benefit for each individual patient." The agency has not yet decided whether the new data ... Pay-Per-View - Family Practice News - HighBeam Research

Straits Gold Pty Ltd withdraws offer for Goldminco Corp-Tenements(2) ...  -  Sep 2, 2008
Ortho Biotech Inc.: Doxil; Ortho-McNeil Pharmaceuticals Inc.: Ditropan XL, Levaquin, Regranex… Storms continue. (F-N) · Storms continue. ... Pay-Per-View - deals - Alacra Store

Merger and Acquisition Scenario  -  Apr 15, 2006
Regranex (Beclapermin); Betaseron (Interferon Beta-1b); TOBI (Tobramycin); (Tobi) Inhalable ... Regranex (Beclapermin). Endocrinology/Metabolism. Diabetes ... $250.00 - Revere Reports - Revere

Panacos Reports Fourth Quarter and Full Year 2006 Financial Results  -  Feb 21, 2007
His career has been highlighted by leadership roles in the development and approval of the prescription drugs LEVAQUIN, TOPAMAX, REMINYL, REGRANEX, ... Genetic Engineering News - Genetic Engineering News (press release)

Gel perigoso se vende em Portugal  -  Sep 6, 2008
O medicamento, Regranex (com a denominação comum becaplermina), ... A FDA recomenda que só se utilize o Regranex quando os benefícios superem os riscos. ... Pravda.Ru

New Treatments for Cancer, Obesity | Newsweek Health: Dean Ornish | …  -  Apr 24, 2008
In 1997, the FDA approved a topical angiogenesis-stimulating gel called Regranex that heals foot ulcers in diabetics. A 2005 study of 24898 diabetic ... Newsweek

Oculus Innovative Sciences Appoints Vice President of Regulatory...  -  Jun 18, 2007
REGRANEX(R) (becaplermin) 0.01% Gel from Phase II to US, EU and ROW approvals. "This is a timely addition to our management team as we are in the midst of ... Genetic Engineering News - Genetic Engineering News (press release)

Strategic Analysis of the European Advanced Wound Management …  -  Jan 10, 2005
In 2003, Johnson & Johnson's growth factor, Regranex contributed a small share of revenues. The sales of hyaluronic acid continued to record low sales with ... Free with registration - PR Newswire - AccessMyLibrary.com

Agennix's Topical Talactoferrin Improved Healing of Diabetic Ulcers  -  Jun 13, 2005
Talactoferrin was also shown to be more effective than becaplermin (Regranex(TM)) in animal experiments. Talactoferrin has been administered to over 500 ... RedOrbit

People on the move: pharmaceutical manufacturing  -  Jun 20, 2007
Redhair will bring his regulatory experience from dealings with applications for Tysabri (natalizumab), betaseron (interferon beta-1b) and Regranex ... In-PharmaTechnologist.com

Earnings Preview: Johnson & Johnson  -  Apr 14, 2008
The company also is facing FDA concerns over the effect of ulcer medication Regranex on cancer death rates for diabetics. Meanwhile, sales of the company's ... Boston Globe

Oral wound healing linked to depression.(PSYCHOLOGICAL NEWS)( …  -  Apr 1, 2006
Article: REGRANEX[R] for treating diabetic foot ulcers.(New ... Dermatology Nursing; August 1, 2003 ; 552 words ... ... treating diabetic foot ulcers. ... Pay-Per-View - Dermatology Nursing - HighBeam Research

Press Release: FDA Proposes Labeling Changes to Over-the-Counter …  -  Dec 20, 2006
Article: FDA Announces New Labeling Changes for Regranex ... M2 Presswire; June 9, 2008 ; 700+ words ...M2 PRESSWIRE-9 June 2008-US Food and Drug ... Pay-Per-View - M2 Presswire - HighBeam Research

A Lifesaving Legacy - New Treatments for Cancer, Obesity  -  Jan 30, 2008
In 1997, the FDA approved a topical angiogenesis-stimulating gel called Regranex that heals foot ulcers in diabetics. A 2005 study of 24898 diabetic ... $2.95 - Newsweek - NewsBank

ZymoGenetics Starts Pivotal rhThrombin Phase III Study  -  Oct 28, 2005
ZymoGenetics' marketed products include Novolin and NovoRapid for diabetes, NovoSeven for hemophilia, Regranex for wound healing, GlucaGen for hypoglycemia ... BioWorld Online - BioWorld Online

Immunomodulatory role of Tinospora cordifolia as an adjuvant in...  -  Jun 1, 2007
Recombinant REGRANEX (Becaplermin; rhPDGF-BB), approved by the US FDA (1997), is found to impair wound contraction, epithelialization and wound strength in ... Free with registration - Indian Journal of Medical Sciences - AccessMyLibrary.com

Healing and preventing the diabetic foot wound: Where technology, …  -  Jun 1, 2007
...'The development of REGRANEX (recombinant PDGF-BB) evoked interest in immune therapy in diabetic non-healing ulcers. It showed beneficial effect, ... Free with registration - Indian Journal of Medical Sciences - AccessMyLibrary.com

Treatment of uncomplicated skin and skin structure infections in the ...  -  Nov 1, 2005
Wound care products can be used to interrupt the inflammatory cascade (Regranex Gel, 0.01%) or reduce MMPs (Promogran) in the chronic wound environment. ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com

短評》中天(4128) - 建議中立  -  Nov 19, 2008
...以WH1 來說，目�?唯一有效藥物Regranex 一年產值約2.7 億美元/年，以轉售價的價格約在8%~15%左�?�來看，約�?�貢�?��?�利2 ~4 仟�?�美元之間，以目�?的股本來看，�?�利空間 ... �?��?�新�?�網

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.